Key Points {#d30e302}
==========

Foundation year 1 and year 2 doctors were both more than twice as likely to prescribe erroneously when compared against medical consultant error rates.No significant differences in severity of error were observed between grades of prescriber.Interventions are needed for all grades of staff, not just junior doctors, to reduce potentially serious prescribing errors.

Introduction {#Sec1}
============

Improving patient safety in healthcare settings is a major concern globally \[[@CR1]\]. Medicines are the most commonly used clinical intervention in healthcare, and errors involving the prescribing, dispensing, administration and monitoring steps of medication use are common \[[@CR2]--[@CR4]\]. Such medication errors can prolong hospital stay and lead to significant patient morbidity and even death \[[@CR5], [@CR6]\]. Each year in England alone, the cost of preventable harm from medicines has been estimated at £750 million \[[@CR7]\].

Prescribing errors in hospitals are particularly common; our systematic review of 65 studies, which used a variety of data collection methods, found a median prescribing error rate of 7 % (interquartile range \[IQR\] 2--14) per medication order, 52 errors (IQR 8--227) per 100 hospital admissions and 24 (IQR 6--216) per 1000 patient days \[[@CR2]\]. Error severity was assessed in 74 % of studies, but comparison between studies was impossible due to the disparity of assessment methods used. Most previous studies were also conducted in only one or two hospitals. Two recent studies conducted in up to nine hospitals in Britain found that 10.9 and 7.5 % of medication items were prescribed incorrectly \[[@CR8], [@CR9]\]. Errors have been presumed to be made more commonly by junior doctors, particularly those in their first year after graduating from university \[[@CR10]\]. The PROTECT study \[[@CR9]\] found that doctors who were in their first and second years of training made more errors than did consultants (7.4 and 8.6 vs. 6.3 %), but Seden et al. \[[@CR8]\] found no difference between error rates of different grades of doctor.

Severity of errors has been measured in a variety of ways in published studies, making direct comparison between studies impossible in our systematic review \[[@CR2]\]. Recent work has suggested there was no association between grades of doctors and the proportion of errors categorised as significant or higher \[[@CR8]\] when correcting for types of prescription and ward speciality. However, whether other factors such as type of drug or route of administration affect the risk of harm to patients is not known.

This study aimed to identify the prevalence of prescribing errors made by junior doctors compared with those made by their senior colleagues and other non-medical prescribers and to investigate predictors of the potentially serious prescribing errors they made.

Methods {#Sec2}
=======

This large prospective study was undertaken in 20 UK National Health Service (NHS) hospitals located across the north-west of England, with data being collected over 7 selected weekdays, each approximately 1 month apart. Three of the hospitals used electronic prescribing at some or all stages of a patient's admission. We used an established definition of a prescribing error as "one which occurs when, as a result of a prescribing decision or prescription-writing process, there is an unintended, significant reduction in the probability of treatment being timely and effective, or increase in the risk of harm when compared with generally accepted practice" \[[@CR11]\]. The definition has been extensively used in previous studies \[[@CR2], [@CR8], [@CR9]\] and is accompanied by lists of situations that should be included and excluded as prescribing errors.

Lead pharmacists from each of the hospitals involved in the study attended two training events, each followed by a question and answer session conducted by DMA and PJL. The lead pharmacists subsequently provided training on data collection at their hospitals to all pharmacists participating in the study, supported by an information booklet providing detailed information on definitions and study requirements. At the study hospitals, inpatient medication orders were written by prescribers (or rewritten when required) directly onto a combined prescription and nursing administration chart, known as 'the drug chart' (normal UK practice). Hospital pharmacists screened all newly prescribed or rewritten inpatient medication orders for prescribing errors as part of their routine pharmacy practice. Data collection occurred between 08:30 and 17:00, Monday to Friday, but included a review of prescriptions written outside these hours. In the UK, ward-based clinical pharmacists routinely check inpatient prescriptions at, or soon after, patient admission, when medicines reconciliation is undertaken. Errors identified at hospital admission may include incorrectly ascertaining and prescribing patients' usual long-term medication. Inpatient drug charts are routinely checked at least daily during weekdays by ward-based clinical pharmacists. Discharge prescriptions are also checked and authorised by a pharmacist prior to supply of medication. Electronic prescription orders could be checked either on the hospital wards or in the hospital pharmacy. Pharmacists may amend or clarify some aspects of prescribing or discuss with the clinical team any recommendations or safety issues at these points of care.

Data were collected on the number of medication orders checked, the grade and type of prescriber (Table [1](#Tab1){ref-type="table"}), the stage of admission when prescribed (on admission, newly prescribed or rewritten during the stay or at discharge) and the number and nature of any prescribing errors. Medications involved in errors were categorised according to the relevant chapter in the British National Formulary (BNF) \[[@CR12]\].Table 1Details of prescriber types in the study hospitalsPrescriber types in hospital practiceDescriptionFoundation year 1Doctors who have recently completed their undergraduate medical degree and who have provisional registration with the UK GMC, in their first year of post-graduate trainingFoundation year 2Doctors in their second year of post-graduate medical training who are fully registered with the GMCFixed-term specialty training appointmentsDoctors in speciality training programmes (usually for 6 years)Non-consultant career grade staffDoctors who have reached a certain level in training and stay working at that level without completing their trainingConsultantsDoctors who hold a certificate for the completion of training (usually after 8 years of training)Pharmacist prescribersSupplementary or independent prescribing pharmacists registered with the General Pharmaceutical CouncilNurse prescribersSupplementary or independent prescribing nurses registered with the Nursing and Midwifery Council*GMC* General Medical Council

Error Validation {#Sec3}
----------------

Two validation panels were formed, both comprising two hospital clinicians and two pharmacists, and both of them met on several occasions to assess prescribing errors reported by pharmacists. The panels verified that each report represented a genuine prescribing error, categorised the type of error that it represented and judged its perceived severity. Panel members discussed each error until consensus was achieved. Severity categories included minor, significant, serious, or potentially lethal errors and were based on rating scales used in previous medication error research \[[@CR13], [@CR14]\]. Additional details about the severity classification scheme are provided in the appendix available in the Electronic Supplementary Material.

Data Analysis {#Sec4}
-------------

The denominator for calculating the prescribing error rate was the number of newly written regular, 'when required' and discharge medication orders screened by hospital pharmacists, including any medication orders omitted \[[@CR15]\]. All confidence intervals (CIs) were calculated at 95 %.

Univariable and multivariable logistic regression models were developed to examine the potential impact of the following variables on the likelihood of a prescribing error: type of prescriber, type of prescription (handwritten vs. electronic), and the stage of hospital stay at which the medication order was issued. Multinomial logistic regression models identified factors predicting the severity of a prescribing error, particularly which factors were associated with a significant or potentially serious error rather than a minor error. All regression models were also adjusted for clustering by hospital site.

Results {#Sec5}
=======

Over the 7 days of data collection, 26,019 patients and 124,260 medication orders were reviewed by pharmacists. Of these, 10,986 medication orders had prescribing errors, resulting in 11,235 prescribing errors being detected. The mean prescribing error rate was 8.8 % (95 % CI 8.6--9.1) errors per 100 medication orders. Prescribing error rates presented by type of prescriber and stage of hospital stay are shown in Table [2](#Tab2){ref-type="table"}.Table 2Prescribing error rates per medication order written by prescriber and prescribing stagePrescriberDescriptionOn admissionDuring stayWhen drug chart re-writtenAt dischargeMissingTotalFY1Orders written14,48710,365756716,271132650,016Errors (*n*)19369193121032874286Errors \[% (95 % CI)\]13.4 (12.4--14.3)8.9 (8.2--9.5)4.1 (3.5--4.8)6.3 (5.8--6.9)6.6 (4.8--8.3)8.6 (8.2--8.9)FY2Orders written14,259708940088127122934,712Errors (*n*)21446101325481123546Errors \[% (95 % CI)\]15.0 (14.1--16)8.6 (7.7--9.5)3.3 (2.7--3.9)6.7 (6--7.5)9.1 (7--11.2)10.2 (9.7--10.7)FTSTAsOrders written661249291901278253916,763Errors (*n*)77729489161371358Errors \[% (95 % CI)\]11.8 (10.5--13)6.0 (5.1--6.8)4.7 (3.3--6.1)5.8 (4.5--7.1)6.9 (4.2--9.5)8.1 (7.5--8.7)NCCGsOrders written126114338196222394374Errors (n)12578293710279Errors \[% (95 % CI)\]9.9 (7.1--12.7)5.4 (4.1--6.8)3.5 (0.3--6.8)5.9 (3.3--8.6)4.2 (1.4--7)6.4 (5.2--7.6)ConsultantsOrders written107214241684461083218Errors (*n*)53676252153Errors \[% (95 % CI)\]4.9 (3--6.9)4.7 (3.6--5.8)3.6 (0--7.4)5.6 (3.2--8.1)1.9 (0--4.5)4.8 (3.8--5.7)Pharmacist prescribersOrders written12411313187Errors (*n*)60006Errors \[% (95 % CI)\]50.0 (0--101.7)0.0 (--)0.0 (--)0.0 (--)3.2 (0--7.2)Nurses prescribersOrders written45636632114561024Errors (*n*)212206453Errors \[% (95 % CI)\]4.6 (2.3--6.9)6.0 (2.1--9.9)0.0 (--)5.3 (0.7--9.9)7.1 (0.1--14.2)5.2 (3.3--7)Missing prescriber detailsOrders written63373367694300955913,966Errors (*n*)84819230180551305Errors \[% (95 % CI)\]13.4 (11.9--14.8)5.7 (4.7--6.7)4.3 (2.2--6.5)6.0 (4.8--7.2)9.8 (5.9--13.8)9.3 (8.6--10.1)TotalOrders written44,49629,01415,18931,502405912,4260Errors (*n*)59102182598198930710,986Errors \[% (95 % CI)\]13.3 (12.8--0)7.5 (7.1--7.9)3.9 (3.5--4.4)6.3 (5.9--6.7)7.6 (6.5--8.7)8.8 (8.6--9.1)*CI* confidence interval, *FY* foundation year 1 or 2 medical trainee, *FTSTA* fixed-term specialty training medical appointment, *NCCGs* non-consultant career grade medical staff

When expressed by the stage of hospital stay, the error rate associated with medication orders at the time of hospital admission (13.3 %, 95 % CI 12.8--13.8) was higher than when newly prescribed medication was initiated during the hospital stay (7.5 %, 95 % CI 7.1--7.9) or when medication was prescribed on discharge from hospital (6.3 %, 95 % CI 5.9--6.7). Foundation doctors (FY1 and FY2) wrote the majority of medication orders (68 %) and had the highest prescribing error rates (FY1 8.6 %, 95 % CI 8.2--8.9; FY2 10.2 %, 95 % CI 9.7--10.7) in comparison with other types of prescriber.

Types of Prescribing Errors, Drug Classes Involved and Severity of Errors {#Sec6}
-------------------------------------------------------------------------

Omission of required drug therapy at the time of hospital admission was by far the most common type of error, occurring almost three times as frequently as the next most numerous type of error, and accounting for 28.5 % of all prescribing errors (Table [3](#Tab3){ref-type="table"}). Under-dosage (10.9 %) and over-dosage (8.4 %) of medication were the next most common error types. Almost half of the errors related to the need for drug therapy (43.5 %), 5.2 % related to selection of a specific drug, 23.5 % related to selection of a dosage regimen, 12.9 % related to administration of a drug, and 14.9 % related to providing a drug product.Table 3Frequency of prescribing errors by error typeError typeErrors*N*% (95 % CI)Need for drug therapy Omission on admission319728.46 (26.96--29.95) Omission on rewrite of prescription chart1050.93 (0.72--1.15) Omission on discharge6756.01 (5.29--6.72) Premature discontinuation210.19 (0.1--0.27) Drug not prescribed but indicated920.82 (0.63--1.01) Continuation for longer than needed840.75 (0.57--0.93) No indication1090.97 (0.76--1.18) Duplication6055.38 (4.85--5.92)Selection of a specific drug Significant allergy380.34 (0.23--0.45) Clinical contra-indication1201.07 (0.86--1.27) Continuation after ADR240.21 (0.12--0.31) Drug interaction600.53 (0.39--0.68) Unintentional prescription of drug3443.06 (2.71--3.42)Selection of dosage regimen No maximum dose3963.52 (3.1--3.95) Drug interaction not taken into account140.12 (0.05--0.2) Dose/rate mismatch10.01 (0--0.03) No dosage alteration after levels out of range60.05 (0.01--0.1) Daily dose divided incorrectly490.44 (0.3--0.57) Overdose9488.44 (7.88--8.99) Underdose122610.91 (10.24--11.58)Administration of drug Incorrect route1171.04 (0.81--1.27) Incorrect formulation4033.59 (3.18--3.99) Administration times incorrect/missing7366.55 (6.01--7.09) IV instructions incorrect/missing1060.94 (0.69--1.2) Start date incorrect/missing840.75 (0.41--1.09)Provide drug product Product/formulation not specified4504.01 (3.56--4.45) Strength/dose missing8507.57 (7--8.14) Route missing1110.99 (0.77--1.2) No signature2101.87 (1.55--2.19) Controlled drug requirements incorrect/missing530.47 (0.33--0.61)Not recorded10.01 (0--0.03)Total11,235100*ADR* adverse drug reaction, *CI* confidence interval, *IV* intravenous

Cardiovascular, central nervous system, respiratory, endocrine, and gastrointestinal drugs were the five most common therapeutic categories associated with prescribing errors, accounting for 73.1 % of all medications involved in errors. Severity grading found that 41.1 % of prescribing errors were minor, 51.6 % were significant and the remaining 7.3 % were serious or potentially life threatening. The rate of potentially serious prescribing errors was higher for consultants and nurse prescribers than all other types of prescriber, as shown in Table [4](#Tab4){ref-type="table"}.Table 4Number and rates of errors by severity and prescriberPotential severityMinorSignificantSerious and potentially lethalMissingTotalFoundation Y11761 (40.3 \[38.3--42.3\])2285 (52.3 \[50.3--54.3\])323 (7.4 \[6.5--8.3\])04369 (100)Foundation Y21480 (40.7 \[38.5--43\])1911 (52.6 \[50.3--54.8\])245 (6.7 \[5.8--7.7\])03636 (100)FTSTAs582 (41.9 \[38.3--45.5\])693 (49.9 \[46.1--53.7\])113 (8.1 \[6.4--9.8\])1 (0.07 \[0--0.21\])1389 (100)NCCGs143 (50.0 \[41.9--58.1\])125 (43.7 \[35.8--51.6\])18 (6.3 \[3.3--9.2\])0286 (100)Consultant68 (43.3 \[34.8--51.8\])71 (45.2 \[36.4--54\])18 (11.5 \[6.4--16.5\])0157 (100)Pharmacist06 (100.0)006 (100)Nurse23 (43.4 \[29.7--57.1\])23 (43.4 \[30.6--56.2\])7 (13.2 \[4.7--21.7\])053 (100)Not recorded563 (42.0 \[38.4--45.7\])685 (51.2 \[47.4--54.9\])91 (6.8 \[5.2--8.4\])01339 (100)Total4620 (41.1 \[39.9--42.4\])5799 (51.6 \[50.3--52.9\])815 (7.25 \[6.7--7.8\])1 (0.01)11,235 (100)Data are presented as *n* (% \[95 % CI\])*CI* confidence interval, *FY* foundation year 1 or 2 medical trainee, *FTSTA* fixed-term specialty training medical appointment, *NCCG* non-consultant career grade medical staff, *OR* odds ratio

Predictors of Likelihood of Prescribing Error {#Sec7}
---------------------------------------------

After controlling for the type of prescriber, prescribing stage and type of prescription, significant differences were observed for all three explanatory variables (Table [5](#Tab5){ref-type="table"}). The multivariable model indicated there were significantly higher rates of prescribing errors for all types of prescriber when compared against consultant prescribing error rates, with FY1 (odds ratio \[OR\] 2.13; 95 % CI 1.80--2.52) and FY2 (OR 2.23; 95 % CI 1.89--2.65) doctors being more than twice as likely to prescribe erroneously as consultants. No significant differences were identified for prescribing error rates for pharmacists (OR 0.84; 95 % CI 0.36--1.93) or nurse prescribers (OR 1.00; 95 % CI 0.71--1.39) when compared against consultant prescribing error rates.Table 5Predictors of errors per orderFactorUnivariableMultivariablePrescriber Consultant1.01.0 Foundation Year 11.9 (1.61--2.24)2.13 (1.8--2.52) Foundation Year 22.24 (1.9--2.65)2.23 (1.89--2.65) FTSTAs1.89 (1.59--2.24)1.84 (1.54--2.19) NCCGs1.42 (1.16--1.75)1.58 (1.29--1.94) Pharmacist0.55 (0.24--1.27)0.84 (0.36--1.93) Nurses1.15 (0.83--1.58)1 (0.71--1.39)Electronic order No1.01.0 Yes0.87 (0.79--0.95)0.88 (0.79--0.97)Prescribing stage During stay1.01.0 On admission1.83 (1.74--1.93)1.7 (1.61--1.8) When drug chart re-written0.51 (0.47--0.56)0.48 (0.43--0.52) Discharge prescription0.82 (0.77--0.88)0.77 (0.72--0.82)Data are presented as OR (95 % CI)*CI* confidence interval, *FY* foundation year 1 or 2 medical trainee, *FTSTA* fixed-term specialty training medical appointment, *NCCG* non-consultant career grade medical staff, *OR* odds ratio

Likewise, the stage of hospital stay was also found to be an important predictor of the likelihood of prescribing errors after controlling for the type of prescriber and the type of prescription. Medication orders issued at the time of hospital admission were 70 % more likely to be associated with a prescribing error (OR 1.70; 95 % CI 1.61--1.80) than those issued during the hospital stay. In contrast, prescribing errors were 52 % less likely (OR 0.48; 95 % CI 0.43--0.52) on drug charts that were rewritten and 23 % less likely on discharge prescriptions (OR 0.77; 95 % CI 0.72--0.82) than medication orders issued during the hospital stay. Electronic prescriptions were 12 % less likely to be associated with a prescribing error than were handwritten prescriptions (OR 0.88; 95 % CI 0.79--0.97) after controlling for type of prescriber and the prescribing stage at which the medication order was issued.

Predictors of Severity of Prescribing Error {#Sec8}
-------------------------------------------

There were no significant differences in severity of error in the multinomial logistic regression model between types of prescriber or whether the medication order was handwritten or generated electronically (Table [6](#Tab6){ref-type="table"}). Potentially serious prescribing errors were significantly less likely to occur on admission (OR 0.46; 95 % CI 0.33--0.66) or when a drug chart was rewritten (OR 0.62; 95 % CI 0.39--0.98) compared with when a medication order was issued during the hospital stay.Table 6Predictors of error severity: multivariable multinomial logistic modelsFactorOdds of being a potentially significant rather than a minor errorOdds of being a potentially serious rather than a minor errorPatient age Decades1 (0.96--1.03)0.93 (0.9--0.96)Therapeutic drug group (BNF chapter) 1. Gastrointestinal1.01.0 2. Cardiovascular6.51 (5.12--8.27)11.96 (7.92--18.06) 3. Respiratory1.89 (1.34--2.67)1.57 (0.61--4.04) 4. Central nervous system1.79 (1.45--2.22)6.69 (4.21--10.64) 5. Infections2.8 (1.91--4.11)5.48 (3.43--8.76) 6. Endocrine3.42 (2.6--4.51)16.48 (10.27--26.46) 7. Obstetrics, gynaecology and urinary tract---- 8. Malignant disease and immunosuppression---- 9. Nutrition and blood1.48 (1.16--1.9)1.13 (0.58--2.2) 10. Musculoskeletal and joint diseases2.8 (1.82--4.31)6.95 (4.21--11.49)Route of administration Oral1.01.0 IV/IM/SC1.07 (0.8--1.43)3.66 (2.98--4.49) Inhalers1.38 (1--1.91)0.37 (0.12--1.16) Other0.65 (0.45--0.92)0.25 (0.09--0.71)Error type Need for drug1.01.0 Selection of specific drug0.35 (0.25--0.49)2.41 (1.63--3.56) Select dosage regimen0.32 (0.27--0.38)0.34 (0.26--0.46) Administration of drug0.04 (0.03--0.05)0.03 (0.01--0.05) Provide drug product0.01 (0.01--0.01)0.04 (0.02--0.06)Prescriber Consultant1.01.0 Foundation Year 10.78 (0.48--1.25)0.63 (0.27--1.45) Foundation Year 20.74 (0.47, 1.16)0.61 (0.26, 1.42) FTSTAs0.75 (0.45, 1.27)0.68 (0.26, 1.75) NCCGs0.61 (0.35, 1.08)0.39 (0.14, 1.08) Pharmacist--1.01 (0.46--2.22) Nurses0.81 (0.33--1.97)0.6 (0.19--1.92)Electronic No1.01.0 Yes0.92 (0.76--1.11)0.97 (0.76--1.23)Prescribing stage During stay1.01.0 On admission1.35 (1.07--1.71)0.46 (0.33--0.66) When drug chart re-written0.75 (0.51--1.1)0.62 (0.39--0.98) Discharge prescription1 (0.74--1.36)0.75 (0.51--1.11)*BNF* British National Formulary, *CI* confidence interval, *IV/IM/SC* intravenous/intramuscular/subcutaneous administration route, *FTSTA* fixed-term specialty training medical appointments, *NCCGs* non-consultant career grade medical staff, OR odds ratio

Potentially serious prescribing errors were significantly more likely to be associated with cardiovascular (OR 11.96; 95 % CI 7.92--18.06), central nervous system (OR 6.69; 95 % CI 4.21--10.64), anti-infective (OR 5.48; 95 % CI 3.43--8.76), endocrine (OR 16.48; 95 % CI 10.27--26.46), and musculoskeletal and joint disease drugs (OR 6.95; 95 % CI 4.21--11.49) than gastrointestinal drugs. Parenteral routes of drug administration (intravenous/intramuscular/subcutaneous) were also three times more likely (OR 3.66; 95 % CI 2.98--4.49) to be associated with serious (rather than minor) prescribing errors than was the oral route of drug administration.

Table [7](#Tab7){ref-type="table"} presents the results from a multinomial logistic regression with interaction terms to explore whether the effect of therapeutic drug group on error severity differed by the route of administration, adjusting for the factors shown in Table [5](#Tab5){ref-type="table"} to be associated with prescribing error severity. There was a 28-fold increase in the odds of a serious prescribing error rather than minor for gastrointestinal drugs administered parenterally compared with medication orders from the same therapeutic group that were not injected (OR 28.63; 95 % CI 10.59--77.45). For all other therapeutic drug groups, all routes of administration had increased odds of serious errors compared with gastrointestinal drugs, and the odds for potentially serious errors were consistently higher for parenteral medication orders.Table 7Effect of route and administration and therapeutic drug group (BNF chapter) on severity of error (adjusted analyses)Therapeutic drug group (BNF chapter)Odds of being a potentially significant rather than a minor error (IV/IM/SC)Odds of being a potentially serious rather than a minor error (IV/IM/SC)NoYesNoYes1. Gastrointestinal1.04.56 (1.71--12.2)1.028.63 (10.59--77.45)2. Cardiovascular7.6 (6.08--9.51)8.04 (5.34--12.09)16.66 (10.41--26.64)64.9 (37.66--111.84)3. Respiratory2.77 (2.19--3.52)2.49 (0.72--8.63)1.02 (0.51--2.03)16.78 (1.99--141.79)4. Central nervous system2.15 (1.8--2.56)0.9 (0.5--1.62)10.87 (6.69--17.65)12.57 (4.89--32.27)5. Infections3.04 (2.18--4.23)4.52 (2.74--7.46)11.39 (7.38--17.57)22.62 (13.82--37.02)6. Endocrine4.33 (3.42--5.49)1.98 (1.19--3.3)22.17 (15.06--32.62)92.84 (37.18--231.8)7. Obstetrics, gynaecology and urinary tract----8. Malignant disease and immunosuppression----9. Nutrition and blood1.48 (1.15--1.91)5.29 (2.12--13.19)1.24 (0.6--2.56)21.31 (6.8--66.78)10. Musculoskeletal and joint diseases2.91 (1.9--4.46)5.32 (0.9--31.25)6.38 (2.54--16.06)184.05 (33.12--1022.82)Data are presented as OR (95 % CI)*BNF* British National Formulary, *CI* confidence interval, *IV/IM/SC* intravenous/intramuscular/subcutaneous administration route, *OR* odds ratio

Discussion {#Sec9}
==========

The problem of prescribing errors in hospitals is substantial and not solely, or even primarily, a problem of the most junior medical prescribers. In this large prospective study in 20 NHS hospitals, prescribing errors occurred in 8.8 % of newly prescribed medication orders, occurring more commonly at hospital admission and on hand-written orders than in those generated electronically. Doctors of all grades made prescribing errors, as did non-medical prescribers, but FY1 and FY2 doctors were more than twice as likely to make prescribing errors as consultant doctors. However, they were not more likely to make serious errors than were more senior medical doctors.

This study was not without limitations. The errors were identified by pharmacists as part of their routine work, a common method of prescribing error data collection \[[@CR8], [@CR9], [@CR16]\]. Failure either to identify or to record errors would result in our data underestimating the actual error rate. Data were recorded on 1 day per month to reduce the impact of such data collection fatigue. Multiple pharmacists were involved, leading to potential variations in data collection practice, even with training. To minimise the impact, all errors recorded were reviewed by a validation panel, although we recognised this could not address variations where errors were not identified or recorded. Identification of the author of handwritten prescriptions is known to be challenging \[[@CR17]\], and the grade of the prescriber was not recorded for 11 % of the medication orders in our study. The impact of misidentification was minimised by having the regular pharmacists, who were familiar with the signatures of the regular doctors, collect the data. Nonetheless, pharmacists only recorded the grade of the doctors writing the prescription, rather than any other doctors involved in making the prescribing decisions. Senior doctors often instruct juniors on ward rounds as to what to write \[[@CR18], [@CR19]\], and the error rate described here for senior doctors could be an underestimate as to the erroneous prescribing with which they were involved.

As with other recent British studies \[[@CR8], [@CR9]\], we have found that prescribing errors are made by all grades of doctors, not just those in their first year of post-graduate training. Deficiencies in undergraduate medical education can therefore only be part of the cause \[[@CR20]\], and changes to it, at best, only part of the solution. If education is to be a means of reducing errors, it must include higher specialist training and the continuing professional development of all prescribers as well as education during the undergraduate years and foundation training. Recent medical education research has identified the importance of minimising the negative effects of transitions \[[@CR21]\]. In particular, it is well recognised that an important transition occurs between being an undergraduate student and being an early career practitioner, and it has been consistently shown that 'becoming a prescriber for real' is one of its most dominant, and negative, features \[[@CR22], [@CR23]\].

Trainees' lack of experience in completing prescriptions before they start work is a well-recognised problem \[[@CR24]\], as is the inappropriate satisfaction of some of them with writing a prescription that 'looks about right' \[[@CR25]\]. Although trainees in other studies have indicated that they want more practical teaching \[[@CR26]\], during undergraduate education, at least, they needed the pressure of a summative assessment to motivate them to take it up \[[@CR27]\]. In the UK, the General Medical Council (GMC) revised their core guidance for medical education, *Tomorrow's Doctors,* to recommend that formal prescribing skills training and practical experience in the NHS be provided for medical students \[[@CR28]\]. Alongside this, a new national assessment of prescribing competence has also been introduced for all medical students in the UK before they graduate from medical school \[[@CR29]\]. It will be important to evaluate the impact of these recent developments on prescribing errors to determine whether they lead to recognisable improvements in patient safety. A study that explored junior doctors' experiences and responses to error found that learning was maximised when errors were formally discussed and constructive feedback was given \[[@CR30]\], although Teunissen et al. \[[@CR31]\] have shown that trainees' openness to negative feedback depends on whether their primary motivation is to be seen to be competent, or to learn from their mistakes.

Over half the errors found in this study were considered significant with the potential to cause some form of patient harm, similar to that found elsewhere \[[@CR8]\], with a further 7.3 % rated potentially serious or life threatening. Serious prescribing errors were far more likely to occur during a patient's hospital stay and when prescribing medication to be administered parenterally. These findings present important early targets for future interventions. Key questions are how and why these errors occur. The quantitative analysis reported here was part of a large mixed-methods study (EQUIP project) in which we also interviewed 30 FY1 doctors about the causes of their prescribing errors, and we draw on this work to interpret our findings \[[@CR32]\]. Complex systems were often involved in causing errors, many of which related to the healthcare environment within which doctors worked, including the impact of busy and stressful working environments or unfamiliarity of the system in which the doctor was working. We found that the FY1 doctors often lacked contextual, rather than basic, knowledge and had difficulty framing clinical problems rather than necessarily lacking specific drug knowledge. Prescribing errors were often found to be due to multiple problems, with several active failures and error-provoking conditions acting together to result in errors. Given this, solutions aimed at a single cause of error are likely to have only limited impact, and multi-factorial interventions addressing many parts of the process of prescribing are likely to be needed \[[@CR33]\].

The literature on causes of prescribing errors is relatively sparse \[[@CR33]\], and the qualitative research previously conducted mainly concentrates on prescribing by junior doctors, usually in the first year of their training. Much less is known about the causes of prescribing errors by doctors further into their training, such as FY2 doctors, and no work has been conducted focusing on causes of errors made by senior doctors or non-medical prescribers, although this study shows that they occur. More needs to be understood about errors made by senior doctors to inform the necessary continuing professional development delivery and systems redesign that is needed to improve patient safety.

Although we found that prescribing errors were 12 % less likely to occur with electronic prescribing systems, we found no difference in the likelihood of serious prescribing errors occurring between hand-written and electronically generated medication orders. This supports the findings from a systematic review of 12 studies that reported computerised provider order-entry systems can reduce minor prescribing errors, with some studies suggesting increasing rates of some more serious errors, such as duplicating orders or failure to discontinue medicines no longer needed \[[@CR34]\].

The stage of the patient's hospital stay during which errors, particularly significant errors, were more likely to occur was at the point of admission and, at that stage, failure to prescribe pre-admission medication was the most common error. There is evidence that conducting medicines reconciliations as soon as possible after admission will reduce omission of long-term medicines \[[@CR35]--[@CR37]\]. Medicines reconciliation is the process by which an up-to-date and accurate list of medicines is created at transitions of care, using information collected from multiple sources as to the pre-admission medication, checked with the current prescribed medicines, and any discrepancies communicated in writing with the current care team \[[@CR38]\]. Our findings support the need for medication reconciliations to improve medication safety at transition points between healthcare settings.

Conclusion {#Sec10}
==========

This study found that junior doctors were twice as likely as senior doctors to make prescribing errors, but that they had similar rates of potentially serious prescribing errors. Potentially serious errors were more likely to be associated with prescriptions for parenteral administration, especially for cardiovascular or endocrine disorders. Further research is needed to target interventions to reduce these high-risk errors and to improve patient safety.
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